{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:12:29Z","timestamp":1790946749075,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s42000-021-00339-6","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T15:02:37Z","timestamp":1638370957000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Nonalcoholic fatty liver disease: lifestyle and quality of life"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8550-8652","authenticated-orcid":false,"given":"Ilias","family":"Vachliotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Goulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Papaioannidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"339_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","volume":"52","author":"E Makri","year":"2021","unstructured":"Makri E, Goulas A, Polyzos SA (2021) Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res 52:25\u201337. https:\/\/doi.org\/10.1016\/j.arcmed.2020.11.010","journal-title":"Arch Med Res"},{"key":"339_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.metabol.2017.02.014","volume":"71","author":"VG Athyros","year":"2017","unstructured":"Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES et al (2017) The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement Metab 71:17\u201332. https:\/\/doi.org\/10.1016\/j.metabol.2017.02.014","journal-title":"An Expert Panel Statement Metab"},{"key":"339_CR3","doi-asserted-by":"publisher","unstructured":"(2016) EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 64:1388\u2013402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"339_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","volume":"46","author":"SA Polyzos","year":"2012","unstructured":"Polyzos SA, Kountouras J, Zavos C, Deretzi G (2012) Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J Clin Gastroenterol 46:272\u2013284. https:\/\/doi.org\/10.1097\/MCG.0b013e31824587e0","journal-title":"J Clin Gastroenterol"},{"key":"339_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.640557","volume":"8","author":"T Hydes","year":"2021","unstructured":"Hydes T, Alam U, Cuthbertson DJ (2021) The impact of macronutrient intake on non-alcoholic fatty liver disease (NAFLD): too much fat, too much carbohydrate, or just too many calories? Front Nutr 8:640557. https:\/\/doi.org\/10.3389\/fnut.2021.640557","journal-title":"Front Nutr"},{"key":"339_CR6","doi-asserted-by":"publisher","first-page":"e3887","DOI":"10.1097\/MD.0000000000003887","volume":"95","author":"MH Wehmeyer","year":"2016","unstructured":"Wehmeyer MH, Zyriax B-C, Jagemann B, Roth E, Windler E, Schulze ZurWiesch J et al (2016) Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern. Medicine 95:e3887. https:\/\/doi.org\/10.1097\/MD.0000000000003887","journal-title":"Medicine"},{"key":"339_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS (2019) Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism 92:82\u201397. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.014","journal-title":"Metabolism"},{"key":"339_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15363","author":"S Hassani Zadeh","year":"2020","unstructured":"Hassani Zadeh S, Mansoori A, Hosseinzadeh M (2020) Relationship between dietary patterns and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Gastroenterol Hepatol. https:\/\/doi.org\/10.1111\/jgh.15363","journal-title":"J Gastroenterol Hepatol"},{"key":"339_CR9","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1002\/hep.30967","volume":"71","author":"M Noureddin","year":"2020","unstructured":"Noureddin M, Zelber-Sagi S, Wilkens LR, Porcel J, Boushey CJ, Le Marchand L et al (2020) Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: the multiethnic cohort. Hepatology 71:1940\u20131952. https:\/\/doi.org\/10.1002\/hep.30967","journal-title":"Hepatology"},{"key":"339_CR10","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00394-018-1711-4","volume":"58","author":"F Asgari-Taee","year":"2019","unstructured":"Asgari-Taee F, Zerafati-Shoae N, Dehghani M, Sadeghi M, Baradaran HR, Jazayeri S (2019) Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Nutr 58:1759\u20131769. https:\/\/doi.org\/10.1007\/s00394-018-1711-4","journal-title":"Eur J Nutr"},{"key":"339_CR11","doi-asserted-by":"publisher","unstructured":"He K, Li Y, Guo X, Zhong L, Tang S (2020) Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis. Br J Nutr:1\u201313. https:\/\/doi.org\/10.1017\/S0007114520000914","DOI":"10.1017\/S0007114520000914"},{"key":"339_CR12","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3945\/ajcn.114.086314","volume":"100","author":"M Chung","year":"2014","unstructured":"Chung M, Ma J, Patel K, Berger S, Lau J, Lichtenstein AH (2014) Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr 100:833\u2013849. https:\/\/doi.org\/10.3945\/ajcn.114.086314","journal-title":"Am J Clin Nutr"},{"key":"339_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/156652409787847191","volume":"9","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kountouras J, Zavos C (2009) Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 9:299\u2013314. https:\/\/doi.org\/10.2174\/156652409787847191","journal-title":"Curr Mol Med"},{"key":"339_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ejcn.2012.220","volume":"67","author":"NJ Kellow","year":"2013","unstructured":"Kellow NJ, Savige GS (2013) Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review. Eur J Clin Nutr 67:239\u2013248. https:\/\/doi.org\/10.1038\/ejcn.2012.220","journal-title":"Eur J Clin Nutr"},{"key":"339_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14309\/ctg.0000000000000040","volume":"10","author":"D Ivancovsky-Wajcman","year":"2019","unstructured":"Ivancovsky-Wajcman D, Zelber-Sagi S, FlissIsakov N, Webb M, Zemel M, Shibolet O et al (2019) Serum soluble receptor for AGE (sRAGE) levels are associated with unhealthy lifestyle and nonalcoholic fatty liver disease. Clin Transl Gastroenterol 10:1\u201310. https:\/\/doi.org\/10.14309\/ctg.0000000000000040","journal-title":"Clin Transl Gastroenterol"},{"key":"339_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.metabol.2018.01.023","volume":"83","author":"SA Palma-Duran","year":"2018","unstructured":"Palma-Duran SA, Kontogianni MD, Vlassopoulos A, Zhao S, Margariti A, Georgoulis M et al (2018) Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults. Metabolism 83:120\u2013127. https:\/\/doi.org\/10.1016\/j.metabol.2018.01.023","journal-title":"Metabolism"},{"key":"339_CR17","doi-asserted-by":"publisher","unstructured":"Perdomo CM, Fr\u00fchbeck G, Escalada J (2019) Impact of nutritional changes on nonalcoholic fatty liver disease. Nutrients 11. https:\/\/doi.org\/10.3390\/nu11030677","DOI":"10.3390\/nu11030677"},{"key":"339_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/hep.27149","volume":"60","author":"KE Koopman","year":"2014","unstructured":"Koopman KE, Caan MWA, Nederveen AJ, Pels A, Ackermans MT, Fliers E et al (2014) Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: a randomized controlled trial. Hepatology 60:545\u2013553. https:\/\/doi.org\/10.1002\/hep.27149","journal-title":"Hepatology"},{"key":"339_CR19","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/hep.31158","volume":"72","author":"D Kim","year":"2020","unstructured":"Kim D, Vazquez-Montesino LM, Li AA, Cholankeril G, Ahmed A (2020) Inadequate physical activity and sedentary behavior are independent predictors of nonalcoholic fatty liver disease. Hepatology 72:1556\u20131568. https:\/\/doi.org\/10.1002\/hep.31158","journal-title":"Hepatology"},{"key":"339_CR20","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.1017\/S1368980021000902","volume":"24","author":"Y-Y Deng","year":"2021","unstructured":"Deng Y-Y, Zhong Q-W, Zhong H-L, Xiong F, Ke Y-B, Chen Y-M (2021) Higher Healthy Lifestyle Score is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and older Chinese adults: a community-based cross-sectional study. Public Health Nutr 24:5081\u20135089. https:\/\/doi.org\/10.1017\/S1368980021000902","journal-title":"Public Health Nutr"},{"key":"339_CR21","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/jech-2014-204989","volume":"69","author":"M Koch","year":"2015","unstructured":"Koch M, Borggrefe J, Schlesinger S, Barbaresko J, Groth G, Jacobs G et al (2015) Association of a lifestyle index with MRI-determined liver fat content in a general population study. J Epidemiol Community Health 69:732\u2013737. https:\/\/doi.org\/10.1136\/jech-2014-204989","journal-title":"J Epidemiol Community Health"},{"key":"339_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.metabol.2013.10.010","volume":"63","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA, Mantzoros CS (2014) Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism 63:161\u2013167. https:\/\/doi.org\/10.1016\/j.metabol.2013.10.010","journal-title":"Metabolism"},{"key":"339_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154203","volume":"111S","author":"SA Polyzos","year":"2020","unstructured":"Polyzos SA, Kang ES, Boutari C, Rhee E-J, Mantzoros CS (2020) Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis. Metabolism 111S:154203. https:\/\/doi.org\/10.1016\/j.metabol.2020.154203","journal-title":"Metabolism"},{"key":"339_CR24","doi-asserted-by":"publisher","unstructured":"Vilar-Gomez E, Nephew LD, Vuppalanchi R, Gawrieh S, Mladenovic A, Pike F et al (2021) High quality diet, physical activity and college education are associated with low risk of NAFLD among the U.S. population. Hepatology. https:\/\/doi.org\/10.1002\/hep.32207","DOI":"10.1002\/hep.32207"},{"key":"339_CR25","doi-asserted-by":"publisher","unstructured":"Saeed N, Nadeau B, Shannon C, Tincopa M (2019) Evaluation of dietary approaches for the treatment of non-alcoholic fatty liver disease: a systematic review. Nutrients 11. https:\/\/doi.org\/10.3390\/nu11123064","DOI":"10.3390\/nu11123064"},{"key":"339_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuaa146","author":"LS Garc\u00eaz","year":"2021","unstructured":"Garc\u00eaz LS, Avelar CR, Fonseca NSS, Costa PRF, Lyra AC, Cunha CM et al (2021) Effect of dietary carbohydrate and lipid modification on clinical and anthropometric parameters in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutr Rev. https:\/\/doi.org\/10.1093\/nutrit\/nuaa146","journal-title":"Nutr Rev"},{"key":"339_CR27","doi-asserted-by":"publisher","unstructured":"Plaz Torres MC, Aghemo A, Lleo A, Bodini G, Furnari M, Marabotto E et al (2019) Mediterranean diet and NAFLD: what we know and questions that still need to be answered. Nutrients 11. https:\/\/doi.org\/10.3390\/nu11122971","DOI":"10.3390\/nu11122971"},{"key":"339_CR28","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.3305\/nh.2015.32.6.10074","volume":"32","author":"R Aller","year":"2015","unstructured":"Aller R, Izaola O, de la Fuente B, De Luis Rom\u00e1n DA (2015) Mediterranean diet is associated with liver histology in patients with non alcoholic fatty liver disease. Nutr Hosp 32:2518\u20132524. https:\/\/doi.org\/10.3305\/nh.2015.32.6.10074","journal-title":"Nutr Hosp"},{"key":"339_CR29","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.clnu.2013.08.014","volume":"33","author":"MD Kontogianni","year":"2014","unstructured":"Kontogianni MD, Tileli N, Margariti A, Georgoulis M, Deutsch M, Tiniakos D et al (2014) Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr 33:678\u2013683. https:\/\/doi.org\/10.1016\/j.clnu.2013.08.014","journal-title":"Clin Nutr"},{"key":"339_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40200-019-00475-2","volume":"19","author":"M Akhlaghi","year":"2020","unstructured":"Akhlaghi M, Ghasemi-Nasab M, Riasatian M (2020) Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations. J Diabetes Metab Disord 19:575\u2013584. https:\/\/doi.org\/10.1007\/s40200-019-00475-2","journal-title":"J Diabetes Metab Disord"},{"key":"339_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.clnesp.2019.10.008","volume":"35","author":"SP Moosavian","year":"2020","unstructured":"Moosavian SP, Arab A, Paknahad Z (2020) The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: a systematic review of randomized controlled trials. Clin Nutr ESPEN 35:40\u201346. https:\/\/doi.org\/10.1016\/j.clnesp.2019.10.008","journal-title":"Clin Nutr ESPEN"},{"key":"339_CR32","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.4254\/wjh.v7.i16.2041","volume":"7","author":"M Whitsett","year":"2015","unstructured":"Whitsett M, VanWagner LB (2015) Physical activity as a treatment of non-alcoholic fatty liver disease: a systematic review. World J Hepatol 7:2041\u20132052. https:\/\/doi.org\/10.4254\/wjh.v7.i16.2041","journal-title":"World J Hepatol"},{"key":"339_CR33","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cgh.2016.04.036","volume":"14","author":"LA Orci","year":"2016","unstructured":"Orci LA, Gariani K, Oldani G, Delaune V, Morel P, Toso C (2016) Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression. Clin Gastroenterol Hepatol 14:1398\u20131411. https:\/\/doi.org\/10.1016\/j.cgh.2016.04.036","journal-title":"Clin Gastroenterol Hepatol"},{"key":"339_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12876-020-01204-3","volume":"20","author":"S-T Wang","year":"2020","unstructured":"Wang S-T, Zheng J, Peng H-W, Cai X-L, Pan X-T, Li H-Q et al (2020) Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. BMC Gastroenterol 20:66. https:\/\/doi.org\/10.1186\/s12876-020-01204-3","journal-title":"BMC Gastroenterol"},{"key":"339_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3727\/105221617X15124844266408","volume":"18","author":"DJ van der Windt","year":"2018","unstructured":"van der Windt DJ, Sud V, Zhang H, Tsung A, Huang H (2018) The effects of physical exercise on fatty liver disease. Gene Expr 18:89","journal-title":"Gene Expr"},{"key":"339_CR36","doi-asserted-by":"publisher","first-page":"4597246","DOI":"10.1155\/2016\/4597246","volume":"2016","author":"CP Oliveira","year":"2016","unstructured":"Oliveira CP, de Lima SP, de Abreu-Silva EO, Marcadenti A (2016) Nutrition and physical activity in nonalcoholic fatty liver disease. J Diabetes Res 2016:4597246. https:\/\/doi.org\/10.1155\/2016\/4597246","journal-title":"J Diabetes Res"},{"key":"339_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2016.08.023","volume":"66","author":"R Hashida","year":"2017","unstructured":"Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T et al (2017) Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review. J Hepatol 66:142\u201352. https:\/\/doi.org\/10.1016\/j.jhep.2016.08.023","journal-title":"J Hepatol"},{"key":"339_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.23736\/S0391-1977.16.02563-3","volume":"42","author":"SA Polyzos","year":"2017","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS (2017) Adipose tissue, obesity and non-alcoholic fatty liver disease. Minerva Endocrinol 42:92\u2013108. https:\/\/doi.org\/10.23736\/S0391-1977.16.02563-3","journal-title":"Minerva Endocrinol"},{"key":"339_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/1753-0407.13086","volume":"13","author":"CJ Baker","year":"2021","unstructured":"Baker CJ, Martinez-Huenchullan SF, D\u2019Souza M, Xu Y, Li M, Bi Y et al (2021) Effect of exercise on hepatic steatosis: are benefits seen without dietary intervention? A systematic review and meta-analysis. J Diabetes 13:63\u201377. https:\/\/doi.org\/10.1111\/1753-0407.13086","journal-title":"J Diabetes"},{"key":"339_CR40","doi-asserted-by":"publisher","first-page":"6318","DOI":"10.3748\/wjg.v22.i27.6318","volume":"22","author":"P Golabi","year":"2016","unstructured":"Golabi P, Locklear CT, Austin P, Afdhal S, Byrns M, Gerber L et al (2016) Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: systematic review. World J Gastroenterol 22:6318\u20136327. https:\/\/doi.org\/10.3748\/wjg.v22.i27.6318","journal-title":"World J Gastroenterol"},{"key":"339_CR41","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/MEG.0000000000001135","volume":"30","author":"T-T Zou","year":"2018","unstructured":"Zou T-T, Zhang C, Zhou Y-F, Han Y-J, Xiong J-J, Wu X-X et al (2018) Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis. Eur J Gastroenterol Hepatol 30:747\u2013755. https:\/\/doi.org\/10.1097\/MEG.0000000000001135","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"339_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/mcg.0000000000001179","volume":"53","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, Henry L (2019) A comprehensive review of patient-reported outcomes in patients with chronic liver diseases. J Clin Gastroenterol 53:331\u2013341. https:\/\/doi.org\/10.1097\/mcg.0000000000001179","journal-title":"J Clin Gastroenterol"},{"key":"339_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15172","author":"S Yamamura","year":"2020","unstructured":"Yamamura S, Nakano D, Hashida R, Tsutsumi T, Kawaguchi T, Okada M et al (2020) Patient-reported outcomes in patients with non-alcoholic fatty liver disease: a narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis. J Gastroenterol Hepatol. https:\/\/doi.org\/10.1111\/jgh.15172","journal-title":"J Gastroenterol Hepatol"},{"key":"339_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1581","author":"ZM Younossi","year":"2020","unstructured":"Younossi ZM, Wong VW, Anstee QM, Romero-Gomez M, Trauner MH, Harrison SA et al (2020) Fatigue and pruritus in patients with advanced fibrosis due to nonalcoholic steatohepatitis: the impact on patient-reported outcomes. Hepatol Commun. https:\/\/doi.org\/10.1002\/hep4.1581","journal-title":"Hepatol Commun"},{"key":"339_CR45","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1111\/liv.14647","volume":"40","author":"PA Cortesi","year":"2020","unstructured":"Cortesi PA, Conti S, Scalone L, Jaffe A, Ciaccio A, Okolicsanyi S et al (2020) Health related quality of life in chronic liver diseases. Liver Int 40:2630\u20132642. https:\/\/doi.org\/10.1111\/liv.14647","journal-title":"Liver Int"},{"key":"339_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jpsychores.2018.07.004","volume":"112","author":"K Assimakopoulos","year":"2018","unstructured":"Assimakopoulos K, Karaivazoglou K, Tsermpini E-E, Diamantopoulou G, Triantos C (2018) Quality of life in patients with nonalcoholic fatty liver disease: a systematic review. J Psychosom Res 112:73\u201380. https:\/\/doi.org\/10.1016\/j.jpsychores.2018.07.004","journal-title":"J Psychosom Res"},{"key":"339_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2016-000106","volume":"3","author":"M Sayiner","year":"2016","unstructured":"Sayiner M, Stepanova M, Pham H, Noor B, Walters M, Younossi ZM (2016) Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease. BMJ Open Gastroenterol 3:e000106. https:\/\/doi.org\/10.1136\/bmjgast-2016-000106","journal-title":"BMJ Open Gastroenterol"},{"key":"339_CR48","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/liv.13706","volume":"38","author":"ZM Younossi","year":"2018","unstructured":"Younossi ZM, Stepanova M, Lawitz E, Charlton M, Loomba R, Myers RP et al (2018) Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib. Liver Int 38:1849\u20131859. https:\/\/doi.org\/10.1111\/liv.13706","journal-title":"Liver Int"},{"key":"339_CR49","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/hep.28416","volume":"63","author":"EB Tapper","year":"2016","unstructured":"Tapper EB, Lai M (2016) Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: a prospective cohort study. Hepatology 63:1184\u20131189. https:\/\/doi.org\/10.1002\/hep.28416","journal-title":"Hepatology"},{"key":"339_CR50","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.cgh.2019.02.024","volume":"17","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Stepanova M, Anstee QM, Lawitz EJ, Wai-Sun Wong V, Romero-Gomez M et al (2019) Reduced patient-reported outcome scores associate with level of fibrosis in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 17:2552-2560.e10. https:\/\/doi.org\/10.1016\/j.cgh.2019.02.024","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00339-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-021-00339-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00339-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T09:10:00Z","timestamp":1644225000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-021-00339-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1007\/s42000-021-00339-6","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"assertion":[{"value":"21 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}